A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
暂无分享,去创建一个
Jingyan Wang | Guo Huang | Guozhi Xia | Jun Zhu | Q. Wei | Yanlong Shi | Haokun Jian | Yuanhai Li | Hongzhu Yu
[1] Xiaojian Zhu,et al. Expression of LOX Suggests Poor Prognosis in Gastric Cancer , 2021, Frontiers in Medicine.
[2] A. Marques,et al. BDNF Impact on Biological Markers of Depression—Role of Physical Exercise and Training , 2021, International journal of environmental research and public health.
[3] Zhifu Sun,et al. A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma , 2021, Journal of cellular and molecular medicine.
[4] Dan Miao,et al. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma , 2021, Frontiers in Oncology.
[5] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[6] Liu Ziyun,et al. Identification of 9-Gene Epithelial–Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts , 2020, Technology in cancer research & treatment.
[7] Shun-Fa Yang,et al. Praeruptorin A reduces metastasis of human hepatocellular carcinoma cells by targeting ERK/MMP1 signaling pathway , 2020, Environmental toxicology.
[8] G. Ferns,et al. Lysyl Oxidase Mechanisms to Mediate Gastrointestinal Cancer Progression , 2020, Gastrointestinal Tumors.
[9] M. Conrad,et al. Emerging roles for non-selenium containing ER-resident glutathione peroxidases in cell signaling and disease , 2020, Biological chemistry.
[10] Henry Yang,et al. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis. , 2020, Journal of Hepatology.
[11] Dong Wang,et al. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma , 2020, Cancer Immunology, Immunotherapy.
[12] L. Kowalski,et al. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy , 2020, Frontiers in Endocrinology.
[13] T. Helbich,et al. Impact of osteopontin on the development of non‐alcoholic liver disease and related hepatocellular carcinoma , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[14] X. Liang,et al. Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway. , 2020, Chemico-biological interactions.
[15] L. Tao,et al. MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[16] G. Turcu,et al. Epithelial-Mesenchymal Transition in Skin Cancers: A Review , 2019, Analytical cellular pathology.
[17] Jian Li,et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. , 2019, Cancer letters.
[18] F. Ponziani,et al. Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice , 2019, Cancers.
[19] C. O’Farrelly,et al. Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function , 2019, International journal of molecular sciences.
[20] Gregory J. Gores,et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management , 2019, Nature Reviews Gastroenterology & Hepatology.
[21] D. Pinato,et al. The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma , 2019, Liver international : official journal of the International Association for the Study of the Liver.
[22] J. DiStefano,et al. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma , 2019, Cancers.
[23] Lan Zhao,et al. Identification of a novel cell cycle‐related gene signature predicting survival in patients with gastric cancer , 2018, Journal of cellular physiology.
[24] Brock Humphries,et al. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway. , 2018, Cancer letters.
[25] Honggang Zhou,et al. Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma , 2018, Journal of Experimental & Clinical Cancer Research.
[26] Wei Liu,et al. Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit , 2018, Clinical Cancer Research.
[27] Yibo Gao,et al. GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer , 2018, Genes.
[28] Xiang Hu,et al. AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition , 2018, Theranostics.
[29] M. Boroni,et al. Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival , 2018, Oncoimmunology.
[30] R. Tohtong,et al. Gadd45β silencing impaired viability and metastatic phenotypes in cholangiocarcinoma cells by modulating the EMT pathway , 2017, Oncology letters.
[31] M. Bruno,et al. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. , 2017, Gastroenterology.
[32] Wei-Lin Jin,et al. Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies. , 2017, Trends in pharmacological sciences.
[33] Georgi Z. Genchev,et al. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction. , 2017, Methods.
[34] A. Chiocchetti,et al. Osteopontin at the Crossroads of Inflammation and Tumor Progression , 2017, Mediators of inflammation.
[35] J. Baulida. Epithelial‐to‐mesenchymal transition transcription factors in cancer‐associated fibroblasts , 2017, Molecular oncology.
[36] R. Weinberg,et al. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.
[37] Ya Cao,et al. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. , 2016, Gastroenterology.
[38] C. Zeng,et al. GADD45B mediates podocyte injury in zebrafish by activating the ROS-GADD45B-p38 pathway , 2016, Cell Death and Disease.
[39] E. Castellón,et al. SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells , 2015, Molecular medicine reports.
[40] S. Costantini,et al. GPX4 and GPX7 Over-Expression in Human Hepatocellular Carcinoma Tissues , 2015, European journal of histochemistry : EJH.
[41] D. Calvisi. When good transforming growth factor‐β turns bad in hepatocellular carcinoma: Axl takes the stage , 2015, Hepatology.
[42] Xuetao Cao,et al. Human CD14+CTLA‐4+ regulatory dendritic cells suppress T‐cell response by cytotoxic T‐lymphocyte antigen‐4‐dependent IL‐10 and indoleamine‐2,3‐dioxygenase production in hepatocellular carcinoma , 2014, Hepatology.
[43] Kol Jia Yong,et al. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma , 2013, Gut.
[44] B. Li,et al. MCM7 expression predicts post‐operative prognosis for hepatocellular carcinoma , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[45] B. Hoffman,et al. Gadd45 stress sensors in malignancy and leukemia. , 2011, Critical reviews in oncogenesis.
[46] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[47] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[48] J. Ringe,et al. Priming integrin α5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis , 2009, Proceedings of the National Academy of Sciences.
[49] J. Ringe,et al. Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis , 2009 .
[50] Zheng Zhang,et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. , 2007, Gastroenterology.
[51] R. Vile. Faculty Opinions recommendation of IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. , 2001 .
[52] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[53] R. Tibshirani. The lasso method for variable selection in the Cox model. , 1997, Statistics in medicine.
[54] E. Hay,et al. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells , 1982, The Journal of cell biology.